Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 5 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Savara Inc | 161,326 | reported | 09 Dec 2025 | tx 29+342,076−76,601 |
| PLUS THERAPEUTICS, INC. | 3,686 | reported | 14 May 2026 | tx 43+975,749−3,369 |
| NEWLINK GENETICS CORP | 0 | reported | 12 Dec 2024 | tx 29+314,973−1,054,172 |
| SCICLONE PHARMACEUTICALS INC | 0 | reported | 13 Oct 2017 | tx 47+575,000−610,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 14 May 2026 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 3,686 | 0.00 USD | deriv |
| 14 May 2026 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 3,686 | 0.00 USD | deriv |
| 09 Dec 2025 | GRANT_AWARD | Savara Inc | 40,000 | 0.00 USD | |
| 14 Nov 2025 | EXERCISE | Savara Inc | 5,860 | 1.46 USD | |
| 14 Nov 2025 | EXERCISE | Savara Inc | 5,860 | 0.00 USD | deriv |
| 13 Aug 2025 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 397,794 | 0.00 USD | deriv |
| 20 Jun 2025 | PURCHASE | Savara Inc | 48,225 | 2.04 USD | |
| 18 Feb 2025 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 40,122 | 0.00 USD | deriv |
| 16 Dec 2024 | SALE | Savara Inc | 8,000 | 3.32 USD | |
| 12 Dec 2024 | GRANT_AWARD | Savara Inc | 40,000 | 0.00 USD | |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 753,093 | — | |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 4,469 | — | |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 19,624 | — | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 35,400 | — | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 35,400 | — | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 135,000 | — | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 35,400 | — | deriv |
| 12 Dec 2024 | OTHER | NEWLINK GENETICS CORP | 28,475 | — | deriv |
| 13 Sept 2024 | PURCHASE | PLUS THERAPEUTICS, INC. | 4,000 | 1.50 USD | |
| 12 Sept 2024 | PURCHASE | PLUS THERAPEUTICS, INC. | 6,285 | 1.35 USD | |
| 11 Sept 2024 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 3,650 | 0.00 USD | deriv |
| 08 May 2024 | PURCHASE | PLUS THERAPEUTICS, INC. | 4,902 | 2.04 USD | first after silence |
| 08 May 2024 | GRANT_AWARD | PLUS THERAPEUTICS, INC. | 9,804 | 0.00 USD | deriv |
| 01 Apr 2024 | TAX_WITHHOLDING | NEWLINK GENETICS CORP | 1,522 | 2.84 USD | |
| 01 Apr 2024 | GRANT_AWARD | NEWLINK GENETICS CORP | 4,500 | 2.84 USD |
1 purchase reported after at least 12 months of silence — most recent on 08 May 2024.